To gain a complete understanding of the effects of EPRS1 on HCC progression, we performed a proteomic analysis on Hep3B cells treated for 24 h with either 300 nmol/L halofuginone or DMSO control. The gene discussed is EPRS1; the disease is hepatocellular carcinoma.